HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 315 filers reported holding HALOZYME THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.92 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $81,314 | -32.6% | 2,129,204 | +0.4% | 0.14% | -41.7% |
Q4 2022 | $120,660 | -99.9% | 2,120,571 | -1.3% | 0.24% | +40.7% |
Q3 2022 | $84,943,000 | -11.1% | 2,148,273 | -1.1% | 0.17% | -2.8% |
Q2 2022 | $95,590,000 | +9.7% | 2,172,478 | -0.6% | 0.18% | +52.6% |
Q1 2022 | $87,149,000 | +12.4% | 2,185,274 | +13.4% | 0.12% | +23.4% |
Q4 2021 | $77,514,000 | -3.3% | 1,927,738 | -2.1% | 0.09% | -5.1% |
Q3 2021 | $80,141,000 | -10.6% | 1,970,055 | -0.3% | 0.10% | -9.2% |
Q2 2021 | $89,693,000 | +8.6% | 1,975,194 | -0.3% | 0.11% | +1.9% |
Q1 2021 | $82,599,000 | -2.6% | 1,981,256 | -0.2% | 0.11% | -4.5% |
Q4 2020 | $84,781,000 | +123.0% | 1,985,026 | +37.2% | 0.11% | +103.6% |
Q3 2020 | $38,024,000 | -0.1% | 1,446,855 | +1.9% | 0.06% | -9.8% |
Q2 2020 | $38,052,000 | +63.2% | 1,419,336 | +9.5% | 0.06% | +27.1% |
Q1 2020 | $23,315,000 | +2.1% | 1,296,003 | +0.6% | 0.05% | +23.1% |
Q4 2019 | $22,835,000 | +13.9% | 1,287,945 | -0.3% | 0.04% | 0.0% |
Q3 2019 | $20,041,000 | – | 1,292,163 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Third Security, LLC | 1,129,551 | $47,091,000 | 6.38% |
First Light Asset Management, LLC | 2,011,350 | $83,853,000 | 5.56% |
TRAN CAPITAL MANAGEMENT, L.P. | 1,353,208 | $56,415,000 | 5.03% |
SNYDER CAPITAL MANAGEMENT L P | 2,920,860 | $121,771,000 | 3.50% |
DOHENY ASSET MANAGEMENT /CA | 120,028 | $5,004,000 | 3.39% |
SILVERARC CAPITAL MANAGEMENT, LLC | 104,945 | $4,375,000 | 2.39% |
Redwood Investments, LLC | 542,764 | $22,628,000 | 1.99% |
Kent Lake Capital LLC | 85,000 | $3,544,000 | 1.44% |
Lisanti Capital Growth, LLC | 263,460 | $10,984,000 | 1.41% |
Bellevue Group AG | 3,011,966 | $125,569,000 | 1.33% |